Khaldoun Tarakji, associate section head of cardiac electrophysiology at the Heart, Vascular, and Thoracic Institute at Cleveland Clinic (Cleveland, USA) has joined Medtronic as vice president and chief medical officer (CMO) of the company’s Cardiac Ablation Solutions (CAS) Operating Unit.
In a statement, Medtronic said that Tarakji will provide senior level medical expertise, strategic planning and guidance on evidence development, and objective medical and patient safety oversight. Tarakji assumes the role previously held by chief medical officer Rob Kowal.
“I am excited to be joining this organisation at such a critical juncture in healthcare technology. Never before have we seen such an emphasis on novel technologies to drive improved patient outcomes for arrythmias,” said Tarakji. “This Medtronic team of engineers and clinical leaders are innovating technologies that are truly advancing care for those suffering from the crippling effects of atrial and ventricular arrhythmias, and I am excited to support the delivery and access of those therapies. I am also incredibly grateful to the physician and nurse partners of whom I have had the pleasure of working alongside during my tenure at Cleveland Clinic, and I look forward to collaborating together again in the future. Most importantly, I am forever grateful to all the patients who entrusted me with their most precious asset, and I hope I continue to serve them on a wider scale in my new role.”
Tarakji has more than a decade-long career as a cardiac electrophysiologist at Cleveland Clinic, and Medtronic describes him as a leader in digital health, helping to pioneer cardiovascular patient care via smart device, including remote patient monitoring. He is the founder of the Heart, Vascular & Thoracic Institute Center for Digital Health Technologies and leads a multidisciplinary team of medical experts in exploring and evaluating the potential impact of personal, digital technology to clinical practice. Tarakji holds the roles of associate professor of medicine at Cleveland Clinic Lerner College of Case Western University and director of the Center for International Medical Education at Cleveland Clinic.
“We are thrilled to welcome Dr Tarakji to Medtronic,” said Rebecca Seidel, president of the Cardiac Ablation Solutions business, which is part of the Cardiovascular Portfolio at Medtronic. “Dr Tarakji is a world-class physician and thought leader in the advanced treatment of atrial fibrillation and other arrhythmias. He is a long-time advisor and clinical investigator for Medtronic and we are honoured that he will be working with us to provide advanced cardiac mapping and ablation solutions for arrhythmia management.”